Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Quantitative imaging features of pretreatment CT predict volumetric response to chemotherapy in patients with colorectal liver metastases.

Creasy JM, Midya A, Chakraborty J, Adams LB, Gomes C, Gonen M, Seastedt KP, Sutton EJ, Cercek A, Kemeny NE, Shia J, Balachandran VP, Kingham TP, Allen PJ, DeMatteo RP, Jarnagin WR, D'Angelica MI, Do RKG, Simpson AL.

Eur Radiol. 2019 Jan;29(1):458-467. doi: 10.1007/s00330-018-5542-8. Epub 2018 Jun 19.

PMID:
29922934
2.

Downstaging by regional chemotherapy of non-resectable isolated colorectal liver metastases.

Link KH, Pillasch J, Formentini A, Sunelaitis E, Leder G, Safi F, Kornmann M, Beger HG.

Eur J Surg Oncol. 1999 Aug;25(4):381-8.

PMID:
10419708
3.

Basic research supported developments of chemotherapy in nonresectable isolated colorectal liver metastases to a protocol of hepatic artery infusion using mitoxantrone, 5-FU + folinic acid and mitomycin C.

Link KH, Kornmann M, Leder G, Pillasch AF, Sunelaitis E, Schatz M, Pressmar J, Beger HG.

Gan To Kagaku Ryoho. 1999 Feb;26(3):269-81. Review.

PMID:
10065089
4.

Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial - PACHA-01 (NCT02494973).

Goéré D, Pignon JP, Gelli M, Elias D, Benhaim L, Deschamps F, Caramella C, Boige V, Ducreux M, de Baere T, Malka D.

BMC Cancer. 2018 Aug 6;18(1):787. doi: 10.1186/s12885-018-4697-7.

5.

Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure.

Boige V, Malka D, Elias D, Castaing M, De Baere T, Goere D, Dromain C, Pocard M, Ducreux M.

Ann Surg Oncol. 2008 Jan;15(1):219-26. Epub 2007 Sep 26.

PMID:
17896145
6.

Regional chemotherapy of non-resectable liver metastases from colorectal cancer - literature and institutional review.

Link KH, Kornmann M, Formentini A, Leder G, Sunelaitis E, Schatz M, Pressmar J, Beger HG.

Langenbecks Arch Surg. 1999 Aug;384(4):344-53.

PMID:
10473854
7.

Selective intra-arterial chemotherapy with floxuridine as second- or third-line approach in patients with unresectable colorectal liver metastases.

Samaras P, Breitenstein S, Haile SR, Stenner-Liewen F, Heinrich S, Feilchenfeldt J, Renner C, Knuth A, Pestalozzi BC, Clavien PA.

Ann Surg Oncol. 2011 Jul;18(7):1924-31. doi: 10.1245/s10434-010-1505-2. Epub 2011 Jan 5.

PMID:
21207165
8.

Conversion to complete resection and/or ablation using hepatic artery infusional chemotherapy in patients with unresectable liver metastases from colorectal cancer: a decade of experience at a single institution.

Ammori JB, Kemeny NE, Fong Y, Cercek A, Dematteo RP, Allen PJ, Kingham TP, Gonen M, Paty PB, Jarnagin WR, D'Angelica MI.

Ann Surg Oncol. 2013 Sep;20(9):2901-7. doi: 10.1245/s10434-013-3009-3. Epub 2013 Jun 15.

PMID:
23771246
9.

Comparison of adjuvant systemic chemotherapy with or without hepatic arterial infusional chemotherapy after hepatic resection for metastatic colorectal cancer.

House MG, Kemeny NE, Gönen M, Fong Y, Allen PJ, Paty PB, DeMatteo RP, Blumgart LH, Jarnagin WR, D'Angelica MI.

Ann Surg. 2011 Dec;254(6):851-6. doi: 10.1097/SLA.0b013e31822f4f88.

PMID:
21975318
10.

Comparison of complete pathologic response and hepatic injuries between hepatic arterial infusion and systemic administration of oxaliplatin in patients with colorectal liver metastases.

Allard MA, Sebagh M, Baillie G, Lemoine A, Dartigues P, Faitot F, Faron M, Boige V, Vitadello F, Vibert E, Elias D, Adam R, Goéré D, Sa Cunha A.

Ann Surg Oncol. 2015;22(6):1925-32. doi: 10.1245/s10434-014-4272-7. Epub 2014 Dec 2.

PMID:
25448804
11.

Diagnostic performance of contrast-enhanced CT-scan in sinusoidal obstruction syndrome induced by chemotherapy of colorectal liver metastases: Radio-pathological correlation.

Cayet S, Pasco J, Dujardin F, Besson M, Orain I, De Muret A, Miquelestorena-Standley E, Thiery J, Genet T, Le Bayon AG.

Eur J Radiol. 2017 Sep;94:180-190. doi: 10.1016/j.ejrad.2017.06.025. Epub 2017 Jul 3.

PMID:
28712693
12.

Adjuvant chemotherapy after resection of colorectal liver metastases in patients at high risk of hepatic recurrence: a comparative study between hepatic arterial infusion of oxaliplatin and modern systemic chemotherapy.

Goéré D, Benhaim L, Bonnet S, Malka D, Faron M, Elias D, Lefèvre JH, Deschamps F, Dromain C, Boige V, Dumont F, De Baere T, Ducreux M.

Ann Surg. 2013 Jan;257(1):114-20. doi: 10.1097/SLA.0b013e31827b9005.

PMID:
23235397
13.

Early tumour response as a survival predictor in previously- treated patients receiving triplet hepatic artery infusion and intravenous cetuximab for unresectable liver metastases from wild-type KRAS colorectal cancer.

Bouchahda M, Boige V, Smith D, Karaboué A, Ducreux M, Hebbar M, Lepère C, Focan C, Guimbaud R, Innominato P, Awad S, Carvalho C, Tumolo S, Truant S, De Baere T, Castaing D, Rougier P, Morère JF, Taieb J, Adam R, Lévi F; ARTBC International.

Eur J Cancer. 2016 Nov;68:163-172. doi: 10.1016/j.ejca.2016.09.011. Epub 2016 Oct 18.

PMID:
27768923
14.

[Hepatic arterial infusion chemotherapy with oxaliplatin in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure].

Tsuchiya M, Watanabe M, Koike J, Kubota Y, Suzuki T, Otsuka Y, Tamura A, Maeda T, Shiokawa H, Arai K, Kurihara A, Funahashi K, Shimada H, Kaneko H.

Gan To Kagaku Ryoho. 2010 Nov;37(12):2594-7. Japanese.

PMID:
21224650
15.

Prospective phase II trial of combination hepatic artery infusion and systemic chemotherapy for unresectable colorectal liver metastases: Long term results and curative potential.

Pak LM, Kemeny NE, Capanu M, Chou JF, Boucher T, Cercek A, Balachandran VP, Kingham TP, Allen PJ, DeMatteo RP, Jarnagin WR, D'Angelica MI.

J Surg Oncol. 2018 Mar;117(4):634-643. doi: 10.1002/jso.24898. Epub 2017 Nov 22.

16.

Texture features of colorectal liver metastases on pretreatment contrast-enhanced CT may predict response and prognosis in patients treated with bevacizumab-containing chemotherapy: a pilot study including comparison with standard chemotherapy.

Ravanelli M, Agazzi GM, Tononcelli E, Roca E, Cabassa P, Baiocchi G, Berruti A, Maroldi R, Farina D.

Radiol Med. 2019 Sep;124(9):877-886. doi: 10.1007/s11547-019-01046-4. Epub 2019 Jun 6.

PMID:
31172448
17.

Prospective evaluation of 18F-fluorodeoxyglucose positron emission tomography in patients receiving hepatic arterial and systemic chemotherapy for unresectable colorectal liver metastases.

Correa-Gallego C, Gavane S, Grewal R, Cercek A, Klimstra DS, Gewirtz AN, Kingham TP, Fong Y, DeMatteo RP, Allen PJ, Jarnagin WR, Kemeny N, D'Angelica MI.

HPB (Oxford). 2015 Jul;17(7):644-50. doi: 10.1111/hpb.12421. Epub 2015 May 23.

18.

Hepatic Arterial Infusion in Combination with Modern Systemic Chemotherapy is Associated with Improved Survival Compared with Modern Systemic Chemotherapy Alone in Patients with Isolated Unresectable Colorectal Liver Metastases: A Case-Control Study.

Dhir M, Jones HL, Shuai Y, Clifford AK, Perkins S, Steve J, Hogg ME, Choudry MH, Pingpank JF, Holtzman MP, Zeh HJ 3rd, Bahary N, Bartlett DL, Zureikat AH.

Ann Surg Oncol. 2017 Jan;24(1):150-158. doi: 10.1245/s10434-016-5418-6. Epub 2016 Jul 18.

PMID:
27431415
19.

Hepatic artery infusion chemotherapy for liver malignancy.

Leal JN, Kingham TP.

Surg Oncol Clin N Am. 2015 Jan;24(1):121-48. doi: 10.1016/j.soc.2014.09.005. Epub 2014 Oct 14. Review.

PMID:
25444472
20.

The Role of Neoadjuvant Therapy in Characterizing Indeterminate Lung Lesions in Patients with Resectable Colorectal Liver Metastases.

Karagkounis G, Cai G, Johnson PT, Pawlik TM, Fishman EK, Choti MA.

Ann Surg Oncol. 2015 Jul;22(7):2201-8. doi: 10.1245/s10434-014-4206-4. Epub 2015 Jan 13.

PMID:
25582736

Supplemental Content

Support Center